000 | 00988 a2200277 4500 | ||
---|---|---|---|
005 | 20250518014734.0 | ||
264 | 0 | _c20191230 | |
008 | 201912s 0 0 eng d | ||
022 | _a1592-8721 | ||
024 | 7 |
_a10.3324/haematol.2018.205989 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aBar-Natan, Michal | |
245 | 0 | 0 |
_aNew insights into the causes of thrombotic events in patients with myeloproliferative neoplasms raise the possibility of novel therapeutic approaches. _h[electronic resource] |
260 |
_bHaematologica _c01 2019 |
||
300 |
_a3-6 p. _bdigital |
||
500 | _aPublication Type: Editorial; Comment | ||
650 | 0 | 4 | _aEndothelial Cells |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aMyeloproliferative Disorders |
650 | 0 | 4 | _aNeoplasms |
650 | 0 | 4 | _aP-Selectin |
650 | 0 | 4 | _aThrombosis |
700 | 1 | _aHoffman, Ronald | |
773 | 0 |
_tHaematologica _gvol. 104 _gno. 1 _gp. 3-6 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.3324/haematol.2018.205989 _zAvailable from publisher's website |
999 |
_c29210411 _d29210411 |